http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018045182-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D255-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
filingDate 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d947bb114ff9b71c328ad74c52920bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84bd0d6315a271b05d9937568550ff1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5005d148ead9c4b8a74a5edbec02469d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120d49065904056022717a2b1cd92364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c8e371142e36864aa9245c2bbeb3a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c246ec3114b6ac6da5ab1706933ca0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5976b9fe9ab1b27b52c4ffbd9d826fe3
publicationDate 2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018045182-A8
titleOfInvention Disubstituted and trisubstituted 1,2,3-triazoles as wnt inhibitors
abstract The present disclosure provides compounds that may be useful for inhibiting Wnt pathway comprising compounds of the formula: (Ia) or (Ib) wherein the variables are as defined herein. In some aspects, the compounds may be used to inhibit the Wnt pathway and used to treat cancer, myocardial infarction, osteopetrosis, or used in the maturation of a precursor cell to a mature cell. Also provided herein in are pharmaceutical compositions of the compounds described herein.
priorityDate 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283

Total number of triples: 33.